Revolution Medicines (RVMD)
(Delayed Data from NSDQ)
$36.27 USD
+0.79 (2.21%)
Updated Apr 23, 2024 04:00 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/13/24 |
---|---|
Current Quarter | -0.75 |
EPS Last Quarter | -1.14 |
Last EPS Surprise | -32.56% |
ABR | 1.08 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -3.18 |
Next Year | -3.40 |
EPS (TTM) | -3.77 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 3.37M | 3.37M | 14.99M | 10.48M |
# of Estimates | 2 | 2 | 3 | 2 |
High Estimate | 6.00M | 6.00M | 24.00M | 18.00M |
Low Estimate | 0.74M | 0.74M | 2.97M | 2.97M |
Year ago Sales | 7.01M | 3.82M | 11.58M | 14.99M |
Year over Year Growth Est. | -51.93% | -11.78% | 29.44% | -30.06% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.75 | -0.76 | -3.18 | -3.40 |
# of Estimates | 8 | 7 | 10 | 9 |
Most Recent Consensus | -0.72 | -0.74 | -3.01 | -3.33 |
High Estimate | -0.67 | -0.73 | -2.99 | -2.36 |
Low Estimate | -0.85 | -0.85 | -3.51 | -4.11 |
Year ago EPS | -0.72 | -0.92 | -3.86 | -3.18 |
Year over Year Growth Est. | -4.17% | 17.39% | 17.62% | -6.96% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 3 | 3 | 3 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 1 | 1 |
Down Last 60 Days | 2 | 2 | 6 | 5 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.75 | -0.76 | -3.18 | -3.40 |
7 Days Ago | -0.75 | -0.76 | -3.18 | -3.40 |
30 Days Ago | -0.75 | -0.76 | -3.17 | -3.39 |
60 Days Ago | -0.80 | -0.83 | -3.20 | -3.15 |
90 Days Ago | -0.80 | -0.83 | -3.20 | -3.15 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.75 | -0.76 | -3.08 | -2.36 |
Zacks Consensus Estimate | -0.75 | -0.76 | -3.18 | -3.40 |
Earnings ESP | 0.00% | 0.00% | 3.21% | 30.66% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.14 | -0.99 | -0.92 | -0.72 | NA |
Estimate | -0.86 | -1.01 | -0.83 | -0.84 | NA |
Difference | -0.28 | 0.02 | -0.09 | 0.12 | -0.06 |
Surprise | -32.56% | 1.98% | -10.84% | 14.29% | -6.78% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more